Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma

NCT02197221

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Clinique Universitaire Saint Luc Brussels, Belgium
  • Grand Hôpital de Charleroi - Site Notre-Dame Charleroi, Belgium
  • Chu Liege Liège, Belgium
  • CHU Dinant-Godinne UCL Namur Yvoir, Belgium
View all 46 locations
View Trial Details
Completed

Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia

NCT02677324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Cornell Medical College New York, United States
View Trial Details
Completed

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

NCT01463670

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • SUNY Downstate Medical Center Brooklyn, New York, United States
View Trial Details
Completed

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

NCT03288480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma

NCT02514668

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number 840003 Scottsdale, Arizona, United States
  • Investigational Site Number 840004 San Francisco, California, United States
  • Investigational Site Number 840011 Detroit, Michigan, United States
  • Investigational Site Number 840015 St Louis, Missouri, United States
View all 18 locations
View Trial Details

Related conditions